Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022
Obstructive sleep apnea (OSA) is one of the most common and serious sleep-related breathing disorders with a high prevalence among patients with cardiovascular (CV) diseases. Despite its widespread presence, OSA remains severely undiagnosed and untreated. CV mortality and morbidity are significantly...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2022/6006127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849306072263688192 |
|---|---|
| author | Satya Preetham Gunta Roopesh Sai Jakulla Aamer Ubaid Kareem Mohamed Abid Bhat Angel López-Candales Nicholas Norgard |
| author_facet | Satya Preetham Gunta Roopesh Sai Jakulla Aamer Ubaid Kareem Mohamed Abid Bhat Angel López-Candales Nicholas Norgard |
| author_sort | Satya Preetham Gunta |
| collection | DOAJ |
| description | Obstructive sleep apnea (OSA) is one of the most common and serious sleep-related breathing disorders with a high prevalence among patients with cardiovascular (CV) diseases. Despite its widespread presence, OSA remains severely undiagnosed and untreated. CV mortality and morbidity are significantly increased in the presence of OSA as it is associated with an increased risk of resistant hypertension, heart failure, arrhythmias, and coronary artery disease. Evaluation and treatment of OSA should focus on recognizing patients at risk of developing OSA. The use of screening questionnaires should be routine, but a formal polysomnography sleep study is fundamental in establishing and classifying OSA. Recognition of OSA patients will allow for the institution of appropriate therapy that should alleviate OSA-related symptoms with the intent of decreasing adverse CV risk. In this review, we focus on the impact OSA has on CV disease and evaluate contemporary OSA treatments. Our goal is to heighten awareness among CV practitioners. |
| format | Article |
| id | doaj-art-395898c2cb4e444d9828bf4895e4ec52 |
| institution | Kabale University |
| issn | 1755-5922 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiovascular Therapeutics |
| spelling | doaj-art-395898c2cb4e444d9828bf4895e4ec522025-08-20T03:55:12ZengWileyCardiovascular Therapeutics1755-59222022-01-01202210.1155/2022/6006127Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022Satya Preetham Gunta0Roopesh Sai Jakulla1Aamer Ubaid2Kareem Mohamed3Abid Bhat4Angel López-Candales5Nicholas Norgard6Department of Internal MedicineDepartment of Internal MedicineDepartment of Internal MedicineDepartment of Internal MedicineDepartment of Sleep MedicineDepartment of Cardiovascular DiseasesDepartment of Internal MedicineObstructive sleep apnea (OSA) is one of the most common and serious sleep-related breathing disorders with a high prevalence among patients with cardiovascular (CV) diseases. Despite its widespread presence, OSA remains severely undiagnosed and untreated. CV mortality and morbidity are significantly increased in the presence of OSA as it is associated with an increased risk of resistant hypertension, heart failure, arrhythmias, and coronary artery disease. Evaluation and treatment of OSA should focus on recognizing patients at risk of developing OSA. The use of screening questionnaires should be routine, but a formal polysomnography sleep study is fundamental in establishing and classifying OSA. Recognition of OSA patients will allow for the institution of appropriate therapy that should alleviate OSA-related symptoms with the intent of decreasing adverse CV risk. In this review, we focus on the impact OSA has on CV disease and evaluate contemporary OSA treatments. Our goal is to heighten awareness among CV practitioners.http://dx.doi.org/10.1155/2022/6006127 |
| spellingShingle | Satya Preetham Gunta Roopesh Sai Jakulla Aamer Ubaid Kareem Mohamed Abid Bhat Angel López-Candales Nicholas Norgard Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 Cardiovascular Therapeutics |
| title | Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 |
| title_full | Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 |
| title_fullStr | Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 |
| title_full_unstemmed | Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 |
| title_short | Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 |
| title_sort | obstructive sleep apnea and cardiovascular diseases sad realities and untold truths regarding care of patients in 2022 |
| url | http://dx.doi.org/10.1155/2022/6006127 |
| work_keys_str_mv | AT satyapreethamgunta obstructivesleepapneaandcardiovasculardiseasessadrealitiesanduntoldtruthsregardingcareofpatientsin2022 AT roopeshsaijakulla obstructivesleepapneaandcardiovasculardiseasessadrealitiesanduntoldtruthsregardingcareofpatientsin2022 AT aamerubaid obstructivesleepapneaandcardiovasculardiseasessadrealitiesanduntoldtruthsregardingcareofpatientsin2022 AT kareemmohamed obstructivesleepapneaandcardiovasculardiseasessadrealitiesanduntoldtruthsregardingcareofpatientsin2022 AT abidbhat obstructivesleepapneaandcardiovasculardiseasessadrealitiesanduntoldtruthsregardingcareofpatientsin2022 AT angellopezcandales obstructivesleepapneaandcardiovasculardiseasessadrealitiesanduntoldtruthsregardingcareofpatientsin2022 AT nicholasnorgard obstructivesleepapneaandcardiovasculardiseasessadrealitiesanduntoldtruthsregardingcareofpatientsin2022 |